Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
COVID-19: Heart patients are particularly affected by SARS-CoV-2 infection
ACE2 is a protein on the surface of cells and serves as the entry gate …
Transcriptional heterogeneity of fibroblasts is a hallmark
of the aging heart. New publication in JCI Insight…
NEWS: Awards & Grants
Stefanie Dimmeler receives Münster Heart Center Lecture Prize
Professor Stefanie Dimmeler had the great honor to sign the golden book of the city of Münster and received…
Night of Science 2024 with Mariana Shumliakivska
Amazing Talk by Mariana Shumliakivska at the Night of Science 2024…
Stefanie Dimmeler honored with prestigious ‚Le Gros Clark Prize Award‘
Professor Stefanie Dimmeler receives ‚Le Gros Clark Prize Award at Oxford University…